PembrolizumabImmunoglobulin-A nephropathy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2036卷 / 1期

关键词：

D O I：

10.1007/s40278-024-71617-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：389 / 389

相关论文

共 50 条

[1] PembrolizumabImmunoglobulin A pemphigus : case report
Reactions Weekly, 2024, 2020 (1) : 380 - 380
[2] PembrolizumabImmunoglobulin G4-related autoimmune pancreatitis and hypopituitarism: case report
Reactions Weekly, 2025, 2048 (1) : 345 - 345
[3] EtanerceptMembranous nephropathy: case report
Reactions Weekly, 2021, 1861 (1) : 127 - 127
[4] LevamisoleMembranous nephropathy: case report
Reactions Weekly, 2018, 1699 (1) : 181 - 181
[5] SulfadiazineCrystal nephropathy: case report
Reactions Weekly, 2023, 1967 (1) : 328 - 328
[6] TozinameranIgA nephropathy: case report
Reactions Weekly, 2022, 1923 (1) : 470 - 470
[7] LevofloxacinOxalate nephropathy: case report
Reactions Weekly, 2019, 1737 (1) : 181 - 181
[8] BevacizumabMembranous nephropathy: case report
Reactions Weekly, 2017, 1657 (1) : 80 - 80
[9] TislelizumabMembranous nephropathy: case report
Reactions Weekly, 2022, 1899 (1) : 355 - 355
[10] NivolumabIgA Nephropathy: case report
Reactions Weekly, 2018, 1684 (1) : 195 - 195

← 1 2 3 4 5 →